2024 annual financial data
Zevra Therapeutics 2024 Operating margin
Direct answer
Operating margin was -368.47%.
Operating income was -87,003,000 USD and net income was -105,511,000 USD.
Operating cash flow was -69,665,000 USD.
Get free Zevra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,612,000 USD
- Operating income
- -87,003,000 USD
- Net income
- -105,511,000 USD
- Operating cash flow
- -69,665,000 USD